Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
thalidomide bms (previously thalidomide celgene)
bristol-myers squibb pharma eeig - talidomidas - daugybinė mieloma - imunosupresantai - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionato, formoterol fumarate dihidratas, glycopyrronium bromidas - plaučių liga, lėtinė obstrukcinė - vaistai nuo obstrukcinių kvėpavimo takų ligų, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antinavikiniai vaistai - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
thalidomide lipomed
lipomed gmbh - talidomidas - daugybinė mieloma - imunosupresantai - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
kyleena
bayer ag - levonorgestrelis - vartojimo į gimdos ertmę sistema - 19,5 mg - plastic iud with progestogen
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
fleree
bayer ag - levonorgestrelis - vartojimo į gimdos ertmę sistema - 13,5 mg - plastic iud with progestogen
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hipofizės ir hipotalaminiai hormonai ir analogai - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
cardace
sanofi winthrop industrie - ramiprilis - tabletės - 2,5 mg; 10 mg - ramipril
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
etrixenal
proenzi s.r.o. - naproksenas - tabletės - 250 mg - naproxen